- Perdue strategy: Run against Reid, Obama, Pelosi
- White House: More changes to contraception mandate coming
- ‘Operation Normandy’ set to send 3,500 volunteers to border to ‘stop an invasion’
- Netanyahu’s spokesman: Safe to fly to Israel
- Oregon vandals smear cars with doughnuts, pastries, chocolate bars
- Obama’s ‘Katrina moment’ leaves his favorability factor at 42 percent
- Feds tout nearly 200 arrests, $625K in seized cash in Texas border crackdown
- Joy Behar: Sarah Palin should be ‘turning letters over on some game show’
- Rhino poacher in South Africa sentenced to 77 years in jail
- John Kerry defies FAA and flies to Israel to talk peace
N.H. gets settlement from drug manufacturer
Question of the Day
CONCORD, N.H. (AP) — New Hampshire is getting $1.7 million from two prescription drug manufacturers that billed the state’s Medicaid program for substandard or improperly marketed medications.
GlaxoSmithKline will pay the state $1.24 million because four drugs it marketed here between 2001-2005, including Paxil CR, did not meet strength and purity standards set by the FDA.
Drug maker Novartis will pay the state $489,000 because it promoted its anti-epileptic drug, Trileptal, for unapproved uses such as treatment of bipolar disorder and neuropathic pain.
Senior Assistant Attorney General Jeff Cahill said no New Hampshire patients suffered harm as a result of the drug frauds.
TWT Video Picks
Retailer pays a price for getting too close to Obama
- CARSON: Costco and the perils of mixing politics and business
- David Perdue defeats Jack Kingston in Georgia Republican Senate primary runoff
- IRS seeks help destroying another 3,200 computer hard drives
- Beretta moving to Tennessee over Maryland gun laws
- D.C. appeals panel deals big blow to Obamacare subsidies
- 'Straight White Guy Festival' supposedly set for Ohio park
- HURT: The cost of 'free' water in Detroit
- EDITORIAL: Obamacare in intensive care
- Pentagon team dispatched to Ukraine amid crisis with Russia
- Contrasting judgments on Obama's health care hours apart; appeals court calls subsidies unlawful
Obama's biggest White House 'fails'
Celebrities turned politicians
Athletes turned actors
20 gadgets that changed the world
Fighting in Iraq